ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005

MicroRNA Biomarkers Linked To Early-Stage Prostate Cancer

February 24, 2012

In Brief: House Members Not Told They were Voting Anti-Impoundment Feature Into Cancer Bill

July 19, 1974

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

Patients on Hypertension Meds Lived Longer, Analysis Shows

January 31, 2014